Faculty of Nursing, University of Alberta, Edmonton, Alberta, Canada.
School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
Prev Med. 2022 Aug;161:107125. doi: 10.1016/j.ypmed.2022.107125. Epub 2022 Jul 2.
Canadian children 5-11 years old became eligible for COVID-19 vaccination on November 19, 2021, with eligibility for younger children expected later. We aimed to descriptively assess parents' COVID-19 vaccine intentions and acceptability of future doses, including co-administration and annual vaccination for their children. We conducted a cross-sectional Canadian online survey of parents from October 14-November 12, 2021, just prior to authorization of the pediatric formulation of the BNT162b2 COVID-19 vaccine for children aged 5-11 years. We assessed parents' intention to vaccinate their children aged 5-11 years, 2-4 years, and 6-23 months; reasons for their intention; and preferences for delivery and access to vaccines. Of 1129 parents, 56% intended to vaccinate their child aged 5-11 years against COVID-19; intentions were lower for children aged 6-23 months (41.9%) and 2-4 years (45.4%). Most parents who intended to vaccinate supported co-administration with routine (61.1%) or influenza (55.4%) vaccines, administration at school (63.6%), receipt of booster doses of COVID-19 vaccine (57.8%), and annual vaccination (56.4%) for their child. Despite parents' high COVID-19 vaccination uptake for themselves (88.8%), intentions for children aged 5-11 years was low. Currently, 56.9% of Canadian children aged 5-11 years have received one dose of a COVID-19 vaccine, and only 37.1% are fully vaccinated. Given that intentions for children <5 years was lower than those 5-11 years, we can also expect low uptake in this group. Parents' preferences regarding delivery and access to COVID-19 vaccination should be considered by public health officials when planning vaccination strategies for children.
加拿大 5-11 岁儿童于 2021 年 11 月 19 日有资格接种 COVID-19 疫苗,预计更年幼的儿童将在之后获得接种资格。我们旨在描述性评估父母对 COVID-19 疫苗的接种意愿和对未来剂量的可接受性,包括为其子女联合接种和每年接种疫苗。我们于 2021 年 10 月 14 日至 11 月 12 日在加拿大进行了一项横断面在线父母调查,就在批准 BNT162b2 COVID-19 疫苗用于 5-11 岁儿童之前。我们评估了父母为其 5-11 岁、2-4 岁和 6-23 个月大的孩子接种疫苗的意愿、其意愿的原因以及对疫苗接种方式和获取途径的偏好。在 1129 名父母中,56%的人打算为其 5-11 岁的孩子接种 COVID-19 疫苗;而对 6-23 个月大(41.9%)和 2-4 岁(45.4%)儿童的接种意愿较低。大多数打算接种疫苗的父母支持与常规(61.1%)或流感(55.4%)疫苗联合接种、在学校接种(63.6%)、接受 COVID-19 疫苗加强剂量(57.8%)和每年为孩子接种疫苗(56.4%)。尽管父母自己接种 COVID-19 疫苗的比例很高(88.8%),但对 5-11 岁儿童的接种意愿却很低。目前,加拿大 5-11 岁儿童中有 56.9%已接种一剂 COVID-19 疫苗,只有 37.1%的儿童已完全接种疫苗。鉴于对 5 岁以下儿童的接种意愿低于 5-11 岁儿童,我们也可以预期该年龄组的接种率较低。在为儿童规划疫苗接种策略时,公共卫生官员应考虑家长对 COVID-19 疫苗接种方式和获取途径的偏好。